ROIV compared with IMVT: revenue, margins and what each company keeps, and the suppliers and customers both name

ROIVRoivant Sciences Ltd.

Mkt capRevenueRevenue

IMVTImmunovant, Inc.

Mkt capRevenueRevenue

Compare

ROIVRoivant Sciences Ltd.

IMVTImmunovant, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

ROIV: latest quarter is a loss; flow not drawable. IMVT: latest quarter not drawable.Method ›

Price

rebased to 0%

ROIV, solidIMVT, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ROIV 6

IMVTImmunovantcustomer

—HanAll Biopharmaunlistedsupplier

—Sumitomo Pharmaunlistedsupplier

—Bayerunlistedsupplier

2 more · ROIV chain ›

Shared 0

No shared counterparties.

Only IMVT 4

ROIVRoivant Sciencessupplier

—Ypsomedunlistedsupplier

—Roivant Sciences GmbHunlistedsupplier

—

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

HanAll

unlistedsupplier

ROIVRoivant Sciences Ltd.

36.90▼−1.65%· post 36.66

Mkt cap$26.7BRevenue$1MQ1 FY26Revenue$8MFY25

IMVTImmunovant, Inc.

29.14▼−1.68%· post 29.57

ClosedOct 30 '26

Mkt cap$6.0BRevenue—Revenue—

Compare

ClosedOct 30 '26

ROIVRoivant Sciences Ltd.

IMVTImmunovant, Inc.

36.90▼−1.65%post 36.66

Price

29.14▼−1.68%post 29.57

$26.7B

Mkt cap

$6.0B

Q1 FY26$1M

Revenue

—

FY25$8M

Revenue

—

ROIV36.90▼−1.65%vsIMVT29.14▼−1.68%ClosedOct 30 '26